SCHEMBL8375671

SCHEMBL8375671

Oc1cc(-c2ccc(Cl)c(Cl)c2)on1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.56
NPC1 O15118 9/20 0.52
RAB9A P51151 9/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 4/20 0.51
HPGD P15428 4/20 0.51
LMNA P02545 3/20 0.49
POLB P06746 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPT P10636 4/20 0.49
TDP1 Q9NUW8 1/20 0.49
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
AHR P35869 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938529 0.81 NOTUM (0.61) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL21776964 0.77 NOTUM (0.71) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8375633 0.76 RAB9A (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
SCHEMBL8375803 0.76 THRB (0.51) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8375802 0.76 ALDH1A1 (0.61) NPC1RAB9AALDH1A1HPGDPOLB
SCHEMBL3479473 0.75 MAPT (0.61) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14541589 0.75 NOTUM (0.54) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL20270439 0.75 PIK3CD (0.42) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL2537431 0.74 MAPT (0.59) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14591926 0.74 MAPT (0.59) NOTUMNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed